EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H25N3O3 |
| Net Charge | 0 |
| Average Mass | 415.493 |
| Monoisotopic Mass | 415.18959 |
| SMILES | [H][C@]12N(C(C)=O)c3ccccc3[C@@]1(C(C)(C)C=C)C[C@]1([H])C([O-])=[NH+]c3ccccc3C(=O)N21 |
| InChI | InChI=1S/C25H25N3O3/c1-5-24(3,4)25-14-20-21(30)26-18-12-8-6-10-16(18)22(31)28(20)23(25)27(15(2)29)19-13-9-7-11-17(19)25/h5-13,20,23H,1,14H2,2-4H3,(H,26,30)/t20-,23-,25+/m1/s1 |
| InChIKey | TXNJQKDZOVFCAQ-XRODADMRSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (2R,3S,11R)-acetylaszonalenin zwitterion (CHEBI:192682) has functional parent (2R,3S,11R)-aszonalenin zwitterion (CHEBI:192681) |
| (2R,3S,11R)-acetylaszonalenin zwitterion (CHEBI:192682) is a benzodiazepine (CHEBI:22720) |
| (2R,3S,11R)-acetylaszonalenin zwitterion (CHEBI:192682) is a zwitterion (CHEBI:27369) |
| UniProt Name | Source |
|---|---|
| (2R,3S,11R)-acetylaszonalenin | UniProt |
| Manual Xrefs | Databases |
|---|---|
| CPD-16900 | MetaCyc |
| Citations |
|---|